{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:26:39Z","timestamp":1757543199175,"version":"3.37.3"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001502","name":"Blue Cross Blue Shield of Michigan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.urolonc.2024.03.015","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T12:42:13Z","timestamp":1712061733000},"page":"220.e1-220.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Variation in management of lymph node positive prostate cancer after radical prostatectomy within a statewide quality improvement consortium"],"prefix":"10.1016","volume":"42","author":[{"given":"Daniel","family":"Triner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Daignault-Newton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udit","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sessine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"Dess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan E V","family":"Caram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tudor","family":"Borza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin B.","family":"Ginsburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian R.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd M.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.03.015_bib0001","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199912093412401","article-title":"Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer","volume":"341","author":"Messing","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0002","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(06)70700-8","article-title":"Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy","volume":"7","author":"Messing","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0003","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.eururo.2017.09.027","article-title":"Survival outcomes of men with lymph node-positive prostate cancer after radical prostatectomy: a comparative analysis of different postoperative management strategies","volume":"73","author":"Touijer","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JU.0000000000002758","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, Part II: principles of active surveillance, principles of surgery, and follow-Up","volume":"208","author":"EJ","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/PPO.0000000000000426","article-title":"Pathologically node-positive prostate cancer: casting for cure when the die is cast?","volume":"26","author":"Ginsburg","year":"2020","journal-title":"Cancer J"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0006","doi-asserted-by":"crossref","first-page":"105.e19","DOI":"10.1016\/j.urolonc.2022.10.021","article-title":"Oncologic outcomes of patients with lymph node invasion at prostatectomy and post-prostatectomy biochemical persistence","volume":"41","author":"Perera","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0007","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.juro.2010.10.057","article-title":"Predicting 15-year prostate cancer specific mortality after radical prostatectomy","volume":"185","author":"ES","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0008","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.euo.2020.08.005","article-title":"Management of patients with node-positive prostate cancer at radical prostatectomy and pelvic lymph node dissection: a systematic review","volume":"3","author":"Marra","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0009","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eururo.2013.03.053","article-title":"Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy","volume":"65","author":"Touijer","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.urolonc.2019.09.026","article-title":"Pelvic lymph node dissection at robot-assisted radical prostatectomy: assessing utilization and nodal metastases within a statewide quality improvement consortium","volume":"38","author":"Lescay","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0011","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eururo.2015.03.036","article-title":"Natural history of clinical recurrence patterns of lymph node\u2013positive prostate cancer after radical prostatectomy","volume":"69","author":"Moschini","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0012","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.juro.2007.05.048","article-title":"Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era","volume":"178","author":"Boorjian","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0013","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.euf.2016.02.018","article-title":"Association between lymph node counts and oncological outcomes in lymph node positive prostate cancer","volume":"3","author":"Mandel","year":"2017","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0014","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.juro.2015.12.074","article-title":"Risk stratification of pN+ prostate cancer after radical prostatectomy from a large single institutional series with long-term follow-up","volume":"195","author":"Marco","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0015","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.juro.2017.06.062","article-title":"Contemporary patterns of care and outcomes of men found to have lymph node metastases at the time of radical prostatectomy","volume":"198","author":"Piotr","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0016","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1200\/JCO.2007.14.2042","article-title":"Role of androgen deprivation therapy for node-positive prostate cancer","volume":"27","author":"Wong","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0017","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2011.02.024","article-title":"Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2\u20134 pN+ prostate cancer: results of a matched analysis","volume":"59","author":"Briganti","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0018","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.eururo.2009.01.046","article-title":"Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy","volume":"55","author":"Da Pozzo","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0019","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0020","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.juro.2012.10.027","article-title":"Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer","volume":"189","author":"Carlsson","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.03.015_bib0021","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eururo.2008.09.043","volume":"55","author":"Briganti","year":"2009","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924003983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924003983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T07:00:27Z","timestamp":1715756427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924003983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1078143924003983"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.03.015","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variation in management of lymph node positive prostate cancer after radical prostatectomy within a statewide quality improvement consortium","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}